ANI Pharmaceuticals to present Phase 4 SYNCHRONICITY trial data on fluocinolone acetonide intravitreal implant at AAO 2026 meeting
ANIP•ANI Pharmaceuticals will present Phase 4 SYNCHRONICITY trial results on chronic non-infectious posterior uveitis at AAO 2026 on Oct. 9, 2026, with post-hoc NEW DAY analyses in diabetic macular edema also scheduled for release.
1. Conference presentations
ANI Pharmaceuticals announced presentations of Phase 4 data for its fluocinolone acetonide intravitreal implant at AAO 2026. SYNCHRONICITY results will be presented in a late-breaking oral session on Oct. 9, 2026; post-hoc NEW DAY analyses comparing rescued and non-rescued patients will be released as an on-demand ePoster, and an encore presentation is scheduled for Hawaiian Eye & Retina on Jan. 21, 2027.
